Educational reference only. Not medical advice. Nothing on this site is for sale.
Latest
CompoundingHHS lets 503A pharmacies compound six peptides under an interim enforcement discretion policyTrial resultRetatrutide beats Ozempic on blood sugar and weight in head-to-head TRANSCEND-T2D-2 trialFDA approvalFDA extends once-weekly insulin icodec (Awiqli) to children 10 and older with type 2 diabetesCompoundingCitizen petition asks FDA not to allow compounding of seven peptides reviewed by its advisory committeeTrial resultSurvodutide SYNCHRONIZE-2 phase 3 results in obesity with type 2 diabetes published in NEJMTrial resultEloraTZP (eloralintide plus tirzepatide) phase 2 results presented at EASD 2026Trial resultOrforglipron ACHIEVE-4 cardiovascular safety trial published in The LancetTrial resultFull TRIUMPH-2 retatrutide results published in The LancetFDA approvalFDA approves insulin efsitora alfa (Onswik), a once-weekly basal insulin for type 2 diabetesWADAWADA publishes 2027 Prohibited List, naming peptides as examples of non-approved substances
Sign in

Articles

4 articles, newest first.

Research-desk articles on peptide science, health and policy. Each one is written from published sources, cites them by number, and says how strong the evidence is.

· Science · 3 min read

Antibiotic candidates in an unlikely place: AI finds 'prionins' hidden inside prion proteins

A deep-learning scan of nearly 2,900 prion and prion-like proteins turned up short peptide fragments that kill bacteria in the lab, and two reduced bacterial levels in a mouse skin-infection model.

· Government · 4 min read

Sport's rulebook catches up with peptides: what the 2027 WADA list changes

The 2027 Prohibited List now names peptides as a group under its catch-all class, while GLP-1 drugs stay on watch as WADA gathers data from studies in athletes.

· Health · 4 min read

Amylin's second act: what the petrelintide phase 2 trials tell us

Two mid-stage trials of a weekly amylin analog report steady weight loss with few stomach-related dropouts, and phase 3 is now under way.

· Explainer · 4 min read

From needle to tablet: how peptide drugs learned to survive the gut

For decades, most peptide drugs had to be injected. A wave of 2025–2026 approvals shows how chemists and formulators are getting peptides through the digestive system, and what is still left to prove.